Kaplan–Meier survival analysis showed that a patient with high pSer16/18 Ephexin1 expression in CRC and LC tumors had markedly shorter survival than a patient with low pSer16/18 Ephexin1 expression (Fig. 6D, E). This evidence concerns the gene NGEF and colorectal carcinoma.